Treatment |
Mechanism of action |
Dose |
Advantages |
Disadvantages |
Successes |
Failures |
Anti-arrhythmic drugs |
Pharmacological attenuation of arrhythmia |
Depends on agent |
Well studied with known effects |
Drug-induced arrhythmia |
None |
Marraffa et al. [15], Enakpene et al. [2] |
Sodium bicarbonate |
Reversal of Na+ blockade |
1 mg/kg loading followed by 0.5 mg/kg every 10 minutes as needed |
Increased survival in arrhythmia |
Aggressive treatment can cause metabolic alkalosis and hypokalemia |
|
Enakpene et al. [2], Marraffa et. al. [15] |
Isoproterenol |
Sympathomimetic action |
1.25 mL/minute followed by 2–20 mL/minute as needed |
Rapid onset of action |
Can cause drug-induced arrhythmia and cardiovascular collapse |
Vaughn et al. [18], Marraffa et al. [15], Enakpene et al. [2], Spinner et al. [20], Eggleston et al. [19] |
|
Transvenous pacing |
Overdrive pacing |
|
Safe and low-risk procedure |
Requires skill and equipment for placement |
Vaughn et al. [18], Marraffa et al. [15], Spinner et al. [20], Eggleston et al. [19] |
|
Lipid emulsion therapy |
Hydrophobic lipid “sink” for toxin |
1.5 mL/kg of 20% ILE followed by 0.25 mg/kg/minute |
Promising results in general drug toxicity management |
Protocols are not standardized |
|
Enakpene et al. [2], Marraffa et al. [15] |